As the COVID-19 pandemic continues to unfold, physicians, nurses, and other caregivers nationwide are facing a shortage of N95 respirators, masks, and other personal protection equipment (PPE), putting the safety of patients and clinicians at risk.

The U.S. Food and Drug Administration (FDA) is sprinting a marathon when it comes to releasing guidance documents and issuing Emergency Use Authorizations (EUA).

On April 6, 2020, the FDA held a Webinar titled, “Enforcement Policy for Personal Protective Equipment (PPE) During COVID-19: Immediately in Effect Guidances.”